Additional file 2 of A novel promising diagnosis model for colorectal advanced adenoma and carcinoma based on the progressive gut microbiota gene biomarkers

Additional file 2: Table S1 The clinical data for the samples in discovery cohort 1 and discovery cohort 2. Table S2 Clinical data and group information for the 616 samples downloaded from Shinichi Yachida et al. (616 metagenome samples). Table S3 The statistics of data in discovery cohort 1 and discovery cohort 2. Table S4 The species biomarkers enriched in advanced adenoma group or normal control group (differential analysis between advanced adenoma patients and normal controls) in discovery cohort 1. Table S5 The progressive disease genus markers for advanced adenoma and colorectal cancer in gut microbiome in discovery cohort 1 and discovery cohort 2. Table S6 The progressive disease species markers for advanced adenoma and colorectal cancer in gut microbiome in discovery cohort 1 and discovery cohort 2. Table S7 The progressive disease gene markers for advanced adenoma and colorectal cancer in gut microbiome in discovery cohort 1 and discovery cohort 2. Table S8 The key parameters for Adenoma Effect Index 1 (AEI1), Adenoma Effect Index 2 (AEI2), CRC Effect Index 1 (CEI1) and CRC Effect Index 2 (CEI2). Table S9 The abundance profiling of the progressive disease gene markers in discovery cohort 1 and discovery cohort 2. Table S10 The cutoff, sensitivity and specificity of score1 and score2.